MDxHealth SA - 14 Year Stock Price History | MDXH
Historical daily share price chart and data for MDxHealth SA since 2012 adjusted for splits and dividends. The latest closing stock price for MDxHealth SA as of September 15, 2026 is 0.67.
- The all-time high MDxHealth SA stock closing price was 12.00 on November 04, 2021.
- The MDxHealth SA 52-week high stock price is 5.33, which is 695.5% above the current share price.
- The MDxHealth SA 52-week low stock price is 0.40, which is 40.3% below the current share price.
- The average MDxHealth SA stock price for the last 52 weeks is 2.46.
| MDxHealth SA Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2026 | 1.8197 | 3.4300 | 4.1500 | 0.4000 | 0.6732 | -81.14% |
| 2025 | 2.6968 | 2.3000 | 5.0000 | 1.4100 | 3.5700 | 50.63% |
| 2024 | 2.7276 | 4.1400 | 4.4800 | 1.5700 | 2.3700 | -39.85% |
| 2023 | 3.6394 | 6.6200 | 7.1500 | 0.3500 | 3.9400 | -40.39% |
| 2022 | 7.7685 | 9.7200 | 10.2700 | 6.1000 | 6.6100 | -30.57% |
| 2021 | 6.7581 | 0.0011 | 12.0000 | 0.0011 | 9.5200 | 951900.00% |
| 2020 | 0.0009 | 0.0011 | 0.0011 | 0.0007 | 0.0010 | -9.09% |
| 2019 | 0.0016 | 0.0026 | 0.0026 | 0.0010 | 0.0011 | -45.00% |
| 2018 | 0.0025 | 0.0039 | 0.0044 | 0.0005 | 0.0020 | -53.49% |
| 2017 | 0.0013 | 0.0005 | 0.0044 | 0.0005 | 0.0043 | 760.00% |
| 2016 | 0.0031 | 0.0042 | 0.0043 | 0.0005 | 0.0005 | -88.64% |
| 2015 | 0.0013 | 0.0006 | 0.0044 | 0.0005 | 0.0044 | 633.33% |
| 2014 | 0.0013 | 0.0040 | 0.0042 | 0.0005 | 0.0006 | -85.00% |
| 2013 | 0.0034 | 0.0030 | 0.0041 | 0.0027 | 0.0040 | 29.03% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.035B | $0.108B |
| MDxHealth SA is a healthcare company which provides actionable molecular diagnostic information for diagnosis and treatment of cancer. The company's tests are based on proprietary gene methylation and other molecular technologies and assist physicians with the diagnosis of cancer. MDxHealth SA is headquartered in Herstal, Belgium. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $43.014B | 42.92 |
| Tempus AI (TEM) | United States | $11.225B | 0.00 |
| 10x Genomics (TXG) | United States | $9.135B | 0.00 |
| Hinge Health (HNGE) | United States | $7.649B | 73.48 |
| Hims & Hers Health (HIMS) | United States | $6.722B | 0.00 |
| Doximity (DOCS) | United States | $4.704B | 29.00 |
| Heartflow (HTFL) | United States | $4.308B | 0.00 |
| IRhythm Holdings (IRTC) | United States | $3.782B | 249.39 |
| Clover Health Investments (CLOV) | United States | $2.709B | 0.00 |
| Privia Health (PRVA) | United States | $2.667B | 99.43 |
| Inspire Medical Systems (INSP) | United States | $2.149B | 32.74 |
| Butterfly Network (BFLY) | United States | $1.973B | 0.00 |
| Schrodinger (SDGR) | United States | $1.532B | 0.00 |
| Omnicell (OMCL) | United States | $1.524B | 21.76 |
| Azenta (AZTA) | United States | $1.404B | 76.29 |
| Enovis (ENOV) | United States | $1.051B | 5.44 |
| Talkspace (TALK) | United States | $0.879B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.659B | 0.00 |
| Phreesia (PHR) | United States | $0.647B | 34.73 |
| Claritev (CTEV) | United States | $0.618B | 0.00 |
| Veradigm (MDRX) | United States | $0.593B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.568B | 0.00 |
| Evolent Health (EVH) | United States | $0.464B | 0.00 |
| Carlsmed (CARL) | United States | $0.419B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.370B | 0.00 |
| CapsoVision (CV) | United States | $0.326B | 0.00 |
| Standard BioTools (LAB) | United States | $0.273B | 0.00 |
| American Well (AMWL) | United States | $0.230B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.144B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.137B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.132B | 0.00 |
| CareCloud (CCLD) | United States | $0.089B | 6.53 |
| Pulmonx (LUNG) | United States | $0.085B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.065B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.062B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.060B | 0.00 |
| Outset Medical (OM) | United States | $0.059B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.050B | 0.00 |
| Precipio (PRPO) | United States | $0.049B | 0.00 |
| 111 (YI) | China | $0.031B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.026B | 0.00 |
| HeartBeam (BEAT) | United States | $0.023B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| HeartSciences (HSCS) | United States | $0.014B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.011B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.010B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.009B | 0.00 |
| ITonic Holdings (ITOC) | China | $0.005B | 0.00 |
| DataMeds AI (MEDS) | United States | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| PROFUSA (PFSA) | United States | $0.002B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |
| Zhongchao (ZCMD) | China | $0.001B | 0.00 |
| TruBridge (TBRG) | United States | $0.000B | 0.00 |